Colitis News - LARVOL Sigma

Colitis	Welcome, Profile Billing Logout

12 3 4 5 6 7 8 9 10 11 12 13...17 18 »

|||||||||| Trial completion date, Trial primary completion date: Standardized Fecal Microbiota Transplantation for Ulcerative Colitis (clinicaltrials.gov) - Aug 31, 2023
P2/3, N=500, Recruiting, Sponsor: The Second Hospital of Nanjing Medical University
Trial completion date: Dec 2032 --> Dec 2025 | Trial primary completion date: Dec 2022 --> Dec 2025

|||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date, IO biomarker: COLIPI: Identification of Predictive Parameters for Colitis in Melanoma Patients Treated With Immunotherapy. (clinicaltrials.gov) - Apr 2, 2019
P=N/A, N=123, Completed, Sponsor: University Medical Center Groningen
Trial completion date: Dec 2032 --> Dec 2025 | Trial primary completion date: Dec 2022 --> Dec 2025 Recruiting --> Completed | N=300 --> 123 | Trial completion date: Mar 2020 --> Apr 2019 | Trial primary completion date: Mar 2020 --> Apr 2019

||||||||||  parimifasor (LYC-30937 EC) / BMS
Trial completion date, Trial termination, Trial primary completion date:  Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis (clinicaltrials.gov) -  Mar 27, 2019
P2, N=112, Terminated,  Sponsor: Lycera Corp.
Recruiting --> Completed | N=300 --> 123 | Trial completion date: Mar 2020 --> Apr 2019 | Trial primary completion date: Mar 2020 --> Apr 2019 Trial completion date: Nov 2018 --> Jul 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Nov 2018 --> Jul 2018; Lack of efficacy of test drug

|||||||||| Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Mission is Remission®: How Can a Disease Self-management Website Change Care? (clinicaltrials.gov) - Mar 1, 2019
P=N/A, N=39, Terminated, Sponsor: IWK Health Centre
Trial completion date: Nov 2018 --> Jul 2018 | Active, not recruiting --> Terminated | Trial primary completion date: Nov 2018 --> Jul 2018; Lack of efficacy of test drug N=200 --> 39 | Trial completion date: Apr 2017 --> Dec 2017 | Enrolling by invitation --> Terminated | Trial primary completion date: Apr 2017 --> Dec 2017; Recruitment challenges and lack of intervention engagement by participants.

|||||||||| Biomarker, Trial completion, Trial completion date, Trial primary completion date: Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease (clinicaltrials.gov) - Feb 27, 2019
P=N/A, N=157, Completed, Sponsor: Herlev Hospital
N=200 --> 39 | Trial completion date: Apr 2017 --> Dec 2017 | Enrolling by invitation --> Terminated | Trial primary completion date: Apr 2017 --> Dec 2017; Recruitment challenges and lack of intervention engagement by participants. Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Feb 2018 | Trial primary completion date: Dec 2018 --> Sep 2016

|||||||||| Trial completion: Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease (clinicaltrials.gov) - Feb 16, 2019
P=N/A, N=103, Completed, Sponsor: Hvidovre University Hospital
Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Feb 2018 | Trial primary completion date: Dec 2018 --> Sep 2016 Active, not recruiting --> Completed

|||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: CALFE: Fecal Calprotectin Collection Protocol (clinicaltrials.gov) - Feb 7, 2019
P=N/A, N=240, Completed, Sponsor: DiaSorin Inc.
Active, not recruiting --> Completed Recruiting --> Completed | N=175 --> 240 | Trial completion date: Mar 2018 --> Aug 2018 | Trial primary completion date: Mar 2018 --> Aug 2018

||||||||||  Rebyota (fecal microbiota, live-jslm) / Ferring
Trial completion, Enrollment change:  PediFETCh: Pediatric FEcal Microbiota Transplant for Ulcerative Colitis (clinicaltrials.gov) -  Jan 30, 2019
P1, N=35, Completed,  Sponsor: McMaster Children's Hospital
Recruiting --> Completed | N=175 --> 240 | Trial completion date: Mar 2018 --> Aug 2018 | Trial primary completion date: Mar 2018 --> Aug 2018 Recruiting --> Completed | N=50 --> 35

||||||||||  Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J
Trial completion:  HARIR: Tracking Biologics Along the Silk Road (clinicaltrials.gov) -  Jan 10, 2019
P=N/A, N=140, Completed,  Sponsor: Janssen Pharmaceutica N.V., Belgium
Recruiting --> Completed | N=50 --> 35 Active, not recruiting --> Completed

|||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Fecal Microbiota Transplant (FMT) in Pediatric Active Crohn's Colitis (clinicaltrials.gov) - Jan 10, 2019
P1/2, N=4, Completed, Sponsor: Stacy A. Kahn
Active, not recruiting --> Completed Recruiting --> Completed | N=60 --> 4 | Trial completion date: Aug 2019 --> Aug 2018 | Trial primary completion date: Mar 2019 --> Aug 2018

|||||||||| Trial completion: Transplantation of Cultured Gut Microflora to Repeat Antibiotic-induced Diarrhea Due to Clostridium Difficile (clinicaltrials.gov) - Jan 9, 2019
P2, N=60, Completed, Sponsor: Per Hellström
Recruiting --> Completed | N=60 --> 4 | Trial completion date: Aug 2019 --> Aug 2018 | Trial primary completion date: Mar 2019 --> Aug 2018 Recruiting --> Completed

||||||||||  obefazimod (ABX464) / Abivax
Trial completion, Immunomodulating:  ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis (clinicaltrials.gov) -  Dec 4, 2018
P2a, N=32, Completed,  Sponsor: Abivax S.A.
Recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Improving Knowledge of Medication in Ulcerative Colitis With an Iphone Application (clinicaltrials.gov) - Nov 27, 2018
P=N/A, N=39, Completed, Sponsor: University of Wisconsin, Madison
Active, not recruiting --> Completed Recruiting --> Completed | N=99 --> 39 | Trial completion date: Dec 2019 --> Dec 2017 | Trial primary completion date: Dec 2018 --> Jun 2017

|||||||||| Trial completion, Trial completion date, Trial primary completion date: Threonine Requirement in IBD Adults and Healthy Adult Controls (clinicaltrials.gov) - Nov 6, 2018
P=N/A, N=86, Completed, Sponsor: Nestl
Recruiting --> Completed | N=99 --> 39 | Trial completion date: Dec 2019 --> Dec 2017 | Trial primary completion date: Dec 2018 --> Jun 2017 Recruiting --> Completed | Trial completion date: May 2017 --> Sep 2018 | Trial primary completion date: May 2017 --> Sep 2018

||||||||||  Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J
Trial completion date, Trial primary completion date:  HARIR: Tracking Biologics Along the Silk Road (clinicaltrials.gov) -  Nov 2, 2018
P=N/A, N=140, Active, not recruiting,  Sponsor: Janssen Pharmaceutica N.V., Belgium
Recruiting --> Completed | Trial completion date: May 2017 --> Sep 2018 | Trial primary completion date: May 2017 --> Sep 2018 Trial completion date: Dec 2019 --> Dec 2018 | Trial primary completion date: Dec 2019 --> Dec 2018

|||||||||| Phase classification, Enrollment change, Trial withdrawal: Fecal Microbiota Transplantation in Patients With Ulcerative Colitis (clinicaltrials.gov) - Oct 17, 2018
P=N/A, N=0, Withdrawn, Sponsor: Turku University Hospital
Trial completion date: Dec 2019 --> Dec 2018 | Trial primary completion date: Dec 2019 --> Dec 2018 Phase classification: P1 --> P=N/A | N=40 --> 0 | Recruiting --> Withdrawn

|||||||||| Trial completion, Phase classification, Enrollment change: Confocal Endomicroscopy During Endoscopy (clinicaltrials.gov) - Oct 17, 2018
P=N/A, N=220, Completed, Sponsor: University of Alberta
Phase classification: P1 --> P=N/A | N=40 --> 0 | Recruiting --> Withdrawn Recruiting --> Completed | Phase classification: P4 --> PN/A | N=400 --> 220

|||||||||| Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date: Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis (clinicaltrials.gov) - Sep 17, 2018
P=N/A, N=0, Withdrawn, Sponsor: The University of Texas Health Science Center at San Antonio
Recruiting --> Completed | Phase classification: P4 --> PN/A | N=400 --> 220 N=100 --> 0 | Trial completion date: Dec 2023 --> Sep 2018 | Recruiting --> Withdrawn | Trial primary completion date: Dec 2023 --> Sep 2018

|||||||||| Trial completion, Trial completion date, Trial primary completion date: Virtual Chromoendoscopy for Colitis Surveillance: A Feasibility Study (clinicaltrials.gov) - Aug 31, 2018
P=N/A, N=60, Completed, Sponsor: King's College Hospital NHS Trust
N=100 --> 0 | Trial completion date: Dec 2023 --> Sep 2018 | Recruiting --> Withdrawn | Trial primary completion date: Dec 2023 --> Sep 2018 Not yet recruiting --> Completed | Trial completion date: Sep 2017 --> Feb 2018 | Trial primary completion date: Jul 2017 --> Nov 2017

|||||||||| Trial completion: Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study (clinicaltrials.gov) - Aug 29, 2018
P=N/A, N=54, Completed, Sponsor: King's College Hospital NHS Trust
Not yet recruiting --> Completed | Trial completion date: Sep 2017 --> Feb 2018 | Trial primary completion date: Jul 2017 --> Nov 2017 Enrolling by invitation --> Completed

|||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Localized Therapeutics for the Treatment of Gastrointestinal Disorders II (clinicaltrials.gov) - Aug 16, 2018
P1, N=3, Completed, Sponsor: Stanford University
Enrolling by invitation --> Completed Recruiting --> Completed | N=10 --> 3 | Trial completion date: Dec 2016 --> Nov 2017 | Trial primary completion date: Dec 2016 --> Nov 2017

|||||||||| Trial completion date, Trial primary completion date: Transplantation of Cultured Gut Microflora to Repeat Antibiotic-induced Diarrhea Due to Clostridium Difficile (clinicaltrials.gov) - Aug 8, 2018
P2, N=60, Recruiting, Sponsor: Per Hellström
Recruiting --> Completed | N=10 --> 3 | Trial completion date: Dec 2016 --> Nov 2017 | Trial primary completion date: Dec 2016 --> Nov 2017 Trial completion date: Dec 2017 --> Dec 2018 | Trial primary completion date: Oct 2016 --> Oct 2018

|||||||||| Trial completion, Trial completion date, Trial primary completion date: Mesalamine and Reproductive Health Study (clinicaltrials.gov) - Aug 2, 2018
P=N/A, N=130, Completed, Sponsor: Harvard School of Public Health
Trial completion date: Dec 2017 --> Dec 2018 | Trial primary completion date: Oct 2016 --> Oct 2018 Active, not recruiting --> Completed | Trial completion date: May 2018 --> Aug 2018 | Trial primary completion date: May 2018 --> Aug 2018

|||||||||| Trial completion, Trial completion date, Trial primary completion date: Study on Cannabinoid Receptor Expression in Gastrointestinal Diseases (clinicaltrials.gov) - Jul 30, 2018
P=N/A, N=31, Completed, Sponsor: Medical University of Graz
Active, not recruiting --> Completed | Trial completion date: May 2018 --> Aug 2018 | Trial primary completion date: May 2018 --> Aug 2018 Active, not recruiting --> Completed | Trial completion date: Apr 2020 --> Jul 2018 | Trial primary completion date: Apr 2020 --> Jul 2018

|||||||||| Enrollment open: Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis (clinicaltrials.gov) - Jul 19, 2018
P=N/A, N=100, Recruiting, Sponsor: The University of Texas Health Science Center at San Antonio
Active, not recruiting --> Completed | Trial completion date: Apr 2020 --> Jul 2018 | Trial primary completion date: Apr 2020 --> Jul 2018 Not yet recruiting --> Recruiting

|||||||||| Enrollment change, Trial termination: Gut Microbiota in the Healthy Population, Inflammatory Bowel Disease Patients, and Their Relatives (clinicaltrials.gov) - Jul 18, 2018
P=N/A, N=103, Terminated, Sponsor: Chinese University of Hong Kong
Not yet recruiting --> Recruiting N=72 --> 103 | Active, not recruiting --> Terminated; Due to study plan

|||||||||| Trial completion: Thermography in Surveillance of Ulcerative Colitis (clinicaltrials.gov) - Jul 17, 2018
P=N/A, N=66, Completed, Sponsor: University Hospital Dubrava
N=72 --> 103 | Active, not recruiting --> Terminated; Due to study plan Active, not recruiting --> Completed

|||||||||| Trial completion, Trial completion date, Trial primary completion date: The Utility of Second Generation Colon Capsule Endoscopy in Ulcerative Colitis (clinicaltrials.gov) - Jul 17, 2018
P=N/A, N=150, Completed, Sponsor: Chinese University of Hong Kong
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: May 2018 --> Jan 2018 | Trial primary completion date: May 2018 --> Jan 2018

||||||||||  Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J
Phase classification:  A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients (clinicaltrials.gov) -  Jul 6, 2018
P=N/A, N=505, Completed,  Sponsor: Janssen Research & Development, LLC
Active, not recruiting --> Completed | Trial completion date: May 2018 --> Jan 2018 | Trial primary completion date: May 2018 --> Jan 2018 Phase classification: P4 --> P=N/A

|||||||||| Trial completion, Trial completion date, HEOR: QUARTZ: QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®) (clinicaltrials.gov) - Jul 5, 2018
P=N/A, N=117, Completed, Sponsor: Ferring Pharmaceuticals
Phase classification: P4 --> P=N/A Active, not recruiting --> Completed | Trial completion date: May 2018 --> Jan 2018

|||||||||| Trial completion date, Trial primary completion date: Fecal Microbiota Transplant (FMT) in Pediatric Active Crohn's Colitis (clinicaltrials.gov) - Jun 29, 2018
P1/2, N=60, Recruiting, Sponsor: Stacy A. Kahn
Active, not recruiting --> Completed | Trial completion date: May 2018 --> Jan 2018 Trial completion date: Aug 2018 --> Aug 2019 | Trial primary completion date: Mar 2018 --> Mar 2019

||||||||||  Rebyota (fecal microbiota, live-jslm) / Ferring
Trial completion date, Trial primary completion date:  PediFETCh: Pediatric FEcal Microbiota Transplant for Ulcerative Colitis (clinicaltrials.gov) -  Jun 26, 2018
P1, N=50, Recruiting,  Sponsor: McMaster Children's Hospital
Trial completion date: Aug 2018 --> Aug 2019 | Trial primary completion date: Mar 2018 --> Mar 2019 Trial completion date: Jul 2018 --> Dec 2018 | Trial primary completion date: Jul 2018 --> Dec 2018

|||||||||| Trial completion: Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets (clinicaltrials.gov) - Jun 26, 2018
P=N/A, N=1731, Completed, Sponsor: Takeda
Trial completion date: Jul 2018 --> Dec 2018 | Trial primary completion date: Jul 2018 --> Dec 2018 Recruiting --> Completed

||||||||||  parimifasor (LYC-30937 EC) / BMS
Trial completion:  An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis (clinicaltrials.gov) -  Jun 15, 2018
P2, N=124, Completed,  Sponsor: Lycera Corp.
Recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion: MicroMICI: Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel Diseases (clinicaltrials.gov) - Jun 1, 2018
P=N/A, N=325, Completed, Sponsor: Assistance Publique - Hôpitaux de Paris
Active, not recruiting --> Completed Active, not recruiting --> Completed

|||||||||| Trial completion: Personalized "Alberta" Diet for Prevention of Relapse in Ulcerative Colitis (clinicaltrials.gov) - May 2, 2018
P=N/A, N=53, Completed, Sponsor: University of Alberta
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  Thykamine (PUR 0110) / PurGenesis
Biomarker, Trial completion, Enrollment change:  Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis (clinicaltrials.gov) -  Apr 18, 2018
P2, N=34, Completed,  Sponsor: PurGenesis Technologies Inc.
Active, not recruiting --> Completed Recruiting --> Completed | N=24 --> 34

|||||||||| Trial completion: FMT in Ulcerative Colitis-Associated Pouchitis (clinicaltrials.gov) - Apr 18, 2018
P2, N=8, Completed, Sponsor: Virginia O. Shaffer
Recruiting --> Completed | N=24 --> 34 Active, not recruiting --> Completed

|||||||||| Trial completion: IMPACT-IBD: Improving OutcoMes in the Pediatric to Adult Care Transition in Inflammatory Bowel Disease (clinicaltrials.gov) - Apr 17, 2018
P=N/A, N=150, Completed, Sponsor: Mount Sinai Hospital, Canada
Active, not recruiting --> Completed Active, not recruiting --> Completed

||||||||||  Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J
Enrollment closed:  HARIR: Tracking Biologics Along the Silk Road (clinicaltrials.gov) -  Apr 17, 2018
P=N/A, N=140, Active, not recruiting,  Sponsor: Janssen Pharmaceutica N.V., Belgium
Active, not recruiting --> Completed Recruiting --> Active, not recruiting

|||||||||| Trial completion, Enrollment change: Development of 'Emma'--a Pediatric IBD Quiz (clinicaltrials.gov) - Apr 13, 2018
P=N/A, N=116, Completed, Sponsor: Mayo Clinic
Recruiting --> Active, not recruiting Not yet recruiting --> Completed | N=200 --> 116

||||||||||  rocatinlimab (KHK4083) / Kyowa Kirin, Amgen
Trial completion, Enrollment change:  A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative Colitis (clinicaltrials.gov) -  Mar 27, 2018
P1, N=155, Completed,  Sponsor: Kyowa Hakko Kirin Co., Ltd
Not yet recruiting --> Completed | N=200 --> 116 Active, not recruiting --> Completed | N=52 --> 155

|||||||||| Trial completion, Enrollment change, Trial completion date: Remote Ischemic Conditioning in Patients With Ulcerative Colitis (clinicaltrials.gov) - Mar 22, 2018
P=N/A, N=22, Completed, Sponsor: Odense University Hospital
Active, not recruiting --> Completed | N=52 --> 155 Recruiting --> Completed | N=38 --> 22 | Trial completion date: Dec 2018 --> Feb 2018

|||||||||| Trial completion: Effect of a Comprehensive Nutrition Support Product on the Nutritional Status of Adults With Inflammatory Bowel Disease (clinicaltrials.gov) - Mar 14, 2018
P=N/A, N=10, Completed, Sponsor: National University of Natural Medicine
Recruiting --> Completed | N=38 --> 22 | Trial completion date: Dec 2018 --> Feb 2018 Active, not recruiting --> Completed

||||||||||  SB012 / Sterna Biologicals
Trial completion:  Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients (clinicaltrials.gov) -  Mar 9, 2018
P2a, N=20, Completed,  Sponsor: Sterna Biologicals GmbH & Co. KG
Active, not recruiting --> Completed Recruiting --> Completed

|||||||||| Trial completion date, HEOR: QUARTZ: QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®) (clinicaltrials.gov) - Mar 7, 2018
P=N/A, N=117, Active, not recruiting, Sponsor: Ferring Pharmaceuticals
Recruiting --> Completed Trial completion date: Feb 2018 --> Mar 2018

||||||||||  parimifasor (LYC-30937 EC) / BMS
Enrollment closed:  Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative Colitis (clinicaltrials.gov) -  Feb 26, 2018
P2, N=120, Active, not recruiting,  Sponsor: Lycera Corp.
Trial completion date: Feb 2018 --> Mar 2018 Recruiting --> Active, not recruiting

|||||||||| Biomarker, Enrollment closed, Trial completion date, Trial primary completion date: Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease (clinicaltrials.gov) - Feb 22, 2018
P=N/A, N=157, Active, not recruiting, Sponsor: Herlev Hospital
Recruiting --> Active, not recruiting Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Jul 2017 --> Dec 2018 | Trial completion date: Jul 2017 --> Dec 2018

|||||||||| Trial completion, Trial initiation date, Trial primary completion date: Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC) (clinicaltrials.gov) - Feb 22, 2018
P1, N=20, Completed, Sponsor: Weill Medical College of Cornell University
Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Jul 2017 --> Dec 2018 | Trial completion date: Jul 2017 --> Dec 2018 Active, not recruiting --> Completed | Initiation date: Jul 2015 --> Oct 2016 | Trial primary completion date: Jul 2019 --> Dec 2016

|||||||||| Trial completion date, Trial initiation date, Trial primary completion date: Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis (clinicaltrials.gov) - Feb 20, 2018
P=N/A, N=100, Not yet recruiting, Sponsor: The University of Texas Health Science Center at San Antonio
Active, not recruiting --> Completed | Initiation date: Jul 2015 --> Oct 2016 | Trial primary completion date: Jul 2019 --> Dec 2016 Initiation date: Jan 2017 --> Mar 2018 | Trial primary completion date: Dec 2022 --> Dec 2023 | Trial completion date: Dec 2022 --> Dec 2023



	Diseases Companies Products Productz Mechanisms of Action Sites